• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Effects of combined hormone therapy on the coagulation-fibrinolytic systems in patients with advanced breast cancer].

作者信息

Fukutomi T, Adachi I, Watanabe T, Nanasawa T, Yamamoto H

出版信息

Gan To Kagaku Ryoho. 1993 May;20(7):957-9.

PMID:8489302
Abstract
摘要

相似文献

1
[Effects of combined hormone therapy on the coagulation-fibrinolytic systems in patients with advanced breast cancer].[联合激素疗法对晚期乳腺癌患者凝血-纤溶系统的影响]
Gan To Kagaku Ryoho. 1993 May;20(7):957-9.
2
Effects of combined tamoxifen and medroxyprogesterone treatment on coagulation-fibrinolytic systems in patients with advanced breast cancer.他莫昔芬与甲羟孕酮联合治疗对晚期乳腺癌患者凝血-纤溶系统的影响。
Acta Oncol. 1993;32(5):573-4.
3
Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report.
Am J Clin Oncol. 1982 Oct;5(5):495-9.
4
Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863).他莫昔芬持续给药与间歇给药以及他莫昔芬间歇/交替给药联合醋酸甲羟孕酮作为晚期乳腺癌一线内分泌治疗的比较：一项欧洲癌症研究与治疗组织（EORTC）III期研究（10863）
Eur J Cancer. 2006 Dec;42(18):3178-85. doi: 10.1016/j.ejca.2006.08.020. Epub 2006 Oct 12.
5
[Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA].[联合激素疗法在晚期或复发性乳腺癌中的疗效——他莫昔芬（TAM）、醋酸甲羟孕酮（MPA）、二者联合以及TAM加MPA交替序贯联合的随机试验]
Gan To Kagaku Ryoho. 1996 Mar;23(4):447-54.
6
Effects of chemoendocrine therapy on the coagulation-fibrinolytic systems in patients with advanced breast cancer. Japan Advanced Breast Cancer Study Group and Japan Clinical Oncology Group.化疗内分泌治疗对晚期乳腺癌患者凝血-纤溶系统的影响。日本晚期乳腺癌研究组和日本临床肿瘤学会。
Jpn J Cancer Res. 1993 Apr;84(4):455-61. doi: 10.1111/j.1349-7006.1993.tb00158.x.
7
Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.晚期乳腺癌的激素治疗：大剂量醋酸甲羟孕酮（MAP）与他莫昔芬（TMX）对比。初步结果。
Eur J Cancer (1965). 1980;Suppl 1:93-8.
8
[Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer].[醋酸甲羟孕酮（MPA）作为Ⅲ期乳腺癌术后辅助内分泌治疗的给药方法及预防复发效果。北九州乳腺癌协作研究组]
Gan To Kagaku Ryoho. 1996 Aug;23(9):1153-60.
9
New regimen of combination hormone therapy (ME-TA-MAP) in the treatment of advanced breast cancer. A pilot study.
Panminerva Med. 1981 Jul-Sep;23(3):157-60.
10
Tamoxifen metabolism is altered by simultaneous administration of medroxyprogesterone acetate in breast cancer patients.在乳腺癌患者中，同时给予醋酸甲羟孕酮会改变他莫昔芬的代谢。
Breast Cancer Res Treat. 1992;22(2):153-6. doi: 10.1007/BF01833345.